Detalhe da pesquisa
1.
Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy.
PLoS Pathog;
17(7): e1009278, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34228762
2.
Late gene expression-deficient cytomegalovirus vectors elicit conventional T cells that do not protect against SIV.
JCI Insight;
8(6)2023 03 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36749635
3.
Myeloid cell tropism enables MHC-E-restricted CD8+ T cell priming and vaccine efficacy by the RhCMV/SIV vaccine.
Sci Immunol;
7(72): eabn9301, 2022 06 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35714200
4.
Cytomegaloviral determinants of CD8+ T cell programming and RhCMV/SIV vaccine efficacy.
Sci Immunol;
6(57)2021 03 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33766849
5.
Non-bronchoscopic Bronchoalveolar Lavage as a Refinement for Safely Obtaining High-quality Samples from Macaques.
Comp Med;
70(6): 520-525, 2020 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33153516
6.
Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine.
Nat Med;
24(2): 130-143, 2018 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29334373